Concepedia

Homer Adams

HA

18

Publications

1.3K

Citations

15

H-Index

2009

Active since

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

Levine Cancer Institute

Emory University

Vejle Sygehus

Homer Adams is an author at Janssen (United States) specializing in immunodeficiencies, health sciences, and immune regulation.

ORCID

Top concepts

Publications per year

2009–2022

18

Publications

18

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma

Tineke Casneuf, Xu Steven Xu, Homer Adams et al. · Blood Advances · 2017 · 218 citations · Full text

High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Homer Adams, Frederik Stevenaert, Jakub Krejcik et al. · Cytometry Part A · 2018 · 154 citations · Full text

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P.M. Verkleij, Marloes E.C. Broekmans, Mark van Duin et al. · Blood Advances · 2021 · 153 citations · Full text

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus

Suzanne Cole, Alice M. Walsh, Xuefeng Yin et al. · Arthritis Research & Therapy · 2018 · 126 citations · Full text

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Tineke Casneuf, Homer Adams, Niels W.C.J. van de Donk et al. · Leukemia · 2020 · 111 citations · Full text

Rows per page

1–5 of 18